Jeffrey C Kwong

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (25)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Stefan Baral

UNITED STATES

View details

Miia Artama

University of Tampere

FINLAND

View details

Randall V. Martin

UNITED STATES

View details

Jessica Widdifield

Women's College Hospital

CANADA

View details

Sasha Bernatsky

McGill University Health Centre

CANADA

View details

JUN MENG

Assistant Professor

Washington State University

UNITED STATES

View details

Tiffany Fitzpatrick

University of Toronto

CANADA

View details

Sarah Buchan

University of Toronto

CANADA

View details

Jay Kaufman

Professor

McGill University

CANADA

View details

Xiaolin Wei

Professor

University of Toronto

CANADA

View details

Natalie Prystajecky

The University of British Columbia

CANADA

View details

Sharmistha Mishra

Associate Professor

University of Toronto

CANADA

View details

Thuan Vo

Tampere University

FINLAND

View details

Helen Petousis-Harris

University of Auckland

NEW ZEALAND

View details

Naveed Janjua

Clinical Professor

The University of British Columbia

CANADA

View details

Beate Sander

University Health Network

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeffrey C Kwong

Research Interests

Explore related searches

Contact this professor

Articles (25)

Safety and health care utilization following COVID-19 vaccination (BNT162b2) among children and youth with juvenile idiopathic arthritis and inflammatory bowel disease: A population-based study

Impact of unequal testing on vaccine effectiveness estimates across two study designs: a simulation study

The Clinical Severity of COVID-19 Variants of Concern: Retrospective Population-Based Analysis

Measures of how well a vaccine works

The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study

Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO’s Targets in Ontario, Canada

A Population-Based Test-Negative Matched Case-Control Analysis of SARS-CoV-2 Vaccine Effectiveness Among Pregnant People in Ontario, Canada

A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection

COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease – a population-based self-controlled case series analysis

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

Characteristics of primary care practices by proportion of patients unvaccinated against SARS-CoV-2: a cross-sectional cohort study

Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

Burden of Illness Associated With Respiratory Syncytial Virus, Influenza, and Coronavirus Disease 2019 in Infants and Young Children in Ontario, Canada, 2018–2023: A Population-Based Canadian Immunization Research Network Study

Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children

Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational COVID-19 studies

Effect of the incremental protection of previous infection against Omicron infection among individuals with a hybrid of infection- and vaccine-induced immunity: a population-based cohort study in Canada

Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling Adults

The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort study

Natural Language Processing for Clinical Laboratory Data Repository Systems: Implementation and Evaluation for Respiratory Viruses

Predictors of all‐cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS‐CoV‐2

Impact of lowering fine particulate matter from major emission sources on mortality in Canada: A nationwide causal analysis

Chronic Exposure to Fine Particulate Matter Increases Mortality Through Pathways of Metabolic and Cardiovascular Disease: Insights From a Large Mediation Analysis

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis

COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis

Collaborators (16)

Stefan Baral

Miia Artama

Randall V. Martin

Jessica Widdifield

Sasha Bernatsky

JUN MENG

Tiffany Fitzpatrick

Sarah Buchan

Jay Kaufman

Xiaolin Wei

Natalie Prystajecky

Sharmistha Mishra

Thuan Vo

Helen Petousis-Harris

Naveed Janjua

Beate Sander

Make your next move.